m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00553)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
ZBTB4
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 3 (METTL3) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by METTL3 | ||
Cell Line | LX2 cell line | Homo sapiens |
Treatment: shMETTL3 LX2 cells
Control: shLuc LX2 cells
|
GSE207909 | |
Regulation |
|
logFC: 8.19E-01 p-value: 3.59E-20 |
More Results | Click to View More RNA-seq Results | |
Representative RIP-seq result supporting the interaction between ZBTB4 and the regulator | ||
Cell Line | MDA-MB-231 | Homo sapiens |
Regulation | logFC: 1.32E+00 | GSE60213 |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | METTL3-mediated m6A modification of Zinc finger and BTB domain-containing protein 4 (ZBTB4) via EZH2 is involved in the CS-induced EMT and in lung cancer. | |||
Target Regulation | Down regulation | |||
Responsed Disease | Lung cancer | ICD-11: 2C25 | ||
Pathway Response | RNA degradation | hsa03018 | ||
Cell Process | Epithelial-mesenchymal transition | |||
In-vitro Model | HBE (Human bronchial epithelial cell line) | |||
In-vivo Model | Male BALB/c mice were grouped into control, CS, CS+AAV-ShMETTL3, and CS+AAV-NC shRNA groups, n = 6 animals per group. Mice in the AAV-ShMETTL3 and AAV-NC shRNA (GeneChem, China) groups were dosed by intranasal instillation after CS exposure for 4 weeks. | |||
Lung cancer [ICD-11: 2C25]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | METTL3-mediated m6A modification of Zinc finger and BTB domain-containing protein 4 (ZBTB4) via EZH2 is involved in the CS-induced EMT and in lung cancer. | |||
Responsed Disease | Lung cancer [ICD-11: 2C25] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Down regulation | |||
Pathway Response | RNA degradation | hsa03018 | ||
Cell Process | Epithelial-mesenchymal transition | |||
In-vitro Model | HBE (Human bronchial epithelial cell line) | |||
In-vivo Model | Male BALB/c mice were grouped into control, CS, CS+AAV-ShMETTL3, and CS+AAV-NC shRNA groups, n = 6 animals per group. Mice in the AAV-ShMETTL3 and AAV-NC shRNA (GeneChem, China) groups were dosed by intranasal instillation after CS exposure for 4 weeks. | |||